vs
Side-by-side financial comparison of American Assets Trust, Inc. (AAT) and Adaptive Biotechnologies Corp (ADPT). Click either name above to swap in a different company.
American Assets Trust, Inc. is the larger business by last-quarter revenue ($110.6M vs $70.9M, roughly 1.6× Adaptive Biotechnologies Corp). American Assets Trust, Inc. runs the higher net margin — 6.1% vs 4.7%, a 1.3% gap on every dollar of revenue. On growth, Adaptive Biotechnologies Corp posted the faster year-over-year revenue change (35.1% vs 1.8%). Over the past eight quarters, Adaptive Biotechnologies Corp's revenue compounded faster (28.1% CAGR vs -0.1%).
Personal Assets Trust is a large British investment trust. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. The chairman is Iain Ferguson CBE.
ExpreS2ion Biotechnologies is a Danish biotechnology company specialised in the development of new vaccines and immunotherapy products based in Hørsholm, Denmark and listed on the Nasdaq First North Growth Market Sweden.
AAT vs ADPT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $110.6M | $70.9M |
| Net Profit | $6.7M | $3.4M |
| Gross Margin | — | 73.6% |
| Operating Margin | 23.4% | -27.1% |
| Net Margin | 6.1% | 4.7% |
| Revenue YoY | 1.8% | 35.1% |
| Net Profit YoY | -16.3% | — |
| EPS (diluted) | $0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.6M | $70.9M | ||
| Q4 25 | $110.1M | $71.7M | ||
| Q3 25 | $109.6M | $94.0M | ||
| Q2 25 | $107.9M | $58.9M | ||
| Q1 25 | $108.6M | $52.4M | ||
| Q4 24 | $113.5M | $47.5M | ||
| Q3 24 | $122.8M | $46.4M | ||
| Q2 24 | $110.9M | $43.2M |
| Q1 26 | $6.7M | $3.4M | ||
| Q4 25 | — | $-13.6M | ||
| Q3 25 | $4.5M | $9.5M | ||
| Q2 25 | $5.5M | $-25.6M | ||
| Q1 25 | $42.5M | $-29.9M | ||
| Q4 24 | — | $-33.7M | ||
| Q3 24 | $16.7M | $-32.1M | ||
| Q2 24 | $11.9M | $-46.2M |
| Q1 26 | — | 73.6% | ||
| Q4 25 | 59.4% | 74.6% | ||
| Q3 25 | 60.5% | 80.7% | ||
| Q2 25 | 62.6% | 69.4% | ||
| Q1 25 | 62.0% | 67.6% | ||
| Q4 24 | 61.3% | 62.0% | ||
| Q3 24 | 65.5% | 64.1% | ||
| Q2 24 | 63.6% | 55.3% |
| Q1 26 | 23.4% | -27.1% | ||
| Q4 25 | 21.1% | -17.8% | ||
| Q3 25 | 22.6% | 10.9% | ||
| Q2 25 | 24.1% | -42.5% | ||
| Q1 25 | 66.3% | -56.4% | ||
| Q4 24 | 26.5% | -71.3% | ||
| Q3 24 | 30.8% | -70.3% | ||
| Q2 24 | 27.8% | -109.6% |
| Q1 26 | 6.1% | 4.7% | ||
| Q4 25 | — | -18.9% | ||
| Q3 25 | 4.1% | 10.2% | ||
| Q2 25 | 5.1% | -43.5% | ||
| Q1 25 | 39.2% | -56.9% | ||
| Q4 24 | — | -71.0% | ||
| Q3 24 | 13.6% | -69.1% | ||
| Q2 24 | 10.7% | -107.0% |
| Q1 26 | $0.08 | — | ||
| Q4 25 | $0.06 | $-0.08 | ||
| Q3 25 | $0.07 | $0.06 | ||
| Q2 25 | $0.09 | $-0.17 | ||
| Q1 25 | $0.70 | $-0.20 | ||
| Q4 24 | $0.14 | $-0.22 | ||
| Q3 24 | $0.28 | $-0.22 | ||
| Q2 24 | $0.20 | $-0.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $118.3M | $77.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.1B | — |
| Total Assets | $2.9B | $505.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $118.3M | $77.6M | ||
| Q4 25 | $129.4M | $70.5M | ||
| Q3 25 | $138.7M | $55.0M | ||
| Q2 25 | $143.7M | $43.2M | ||
| Q1 25 | $143.9M | $50.6M | ||
| Q4 24 | $425.7M | $47.9M | ||
| Q3 24 | $533.0M | $38.1M | ||
| Q2 24 | $114.9M | $59.8M |
| Q1 26 | — | — | ||
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.2B | $218.8M | ||
| Q3 25 | $1.2B | $204.4M | ||
| Q2 25 | $1.2B | $179.7M | ||
| Q1 25 | $1.2B | $190.4M | ||
| Q4 24 | $1.2B | $202.7M | ||
| Q3 24 | $1.2B | $223.8M | ||
| Q2 24 | $1.2B | $241.6M |
| Q1 26 | $2.9B | $505.9M | ||
| Q4 25 | $2.9B | $512.7M | ||
| Q3 25 | $2.9B | $490.6M | ||
| Q2 25 | $3.0B | $496.6M | ||
| Q1 25 | $3.0B | $510.9M | ||
| Q4 24 | $3.3B | $539.4M | ||
| Q3 24 | $3.4B | $558.5M | ||
| Q2 24 | $3.0B | $584.9M |
| Q1 26 | — | — | ||
| Q4 25 | 1.48× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.72× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AAT
| Rental income | $104.4M | 94% |
| Other | $6.2M | 6% |
ADPT
Segment breakdown not available.
